Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Addtech sharpens its organisation for future growth

By adapting its operations and further strengthening the network between the companies, Addtech sharpens its organisation to best capture future growth opportunities. The new organisation will come into effect on 1 October 2021 and will comprise five business areas with clear niche strategies. “Addtech’s business concept has been successfull for many years. Its strengths are our unique culture, with its clear entrepreneurial focus, and how we cluster our companies to build networks that foster growth. The recent years increased focus on sustainable technical solutions, combined with a

Following the Swedish success – Lantmännen launches Climate & Nature in Finland

Climate & Nature, Lantmännen’s cultivation programme for the Farming of the Future, is now being launched in Finland. The initial aim is to achieve a 15 percent climate footprint reduction of Finnish rye crops. This is the first expansion on a foreign market since the programme was initiated in 2015 and since then, the carbon footprint of Swedish wheat farming has been reduced by approximately 30 percent.Climate & Nature is a Lantmännen programme for Farming of the Future that includes specific measures to reduce climate impact and boost biodiversity. The first step towards a more

Read original

Finnair adds frequencies and destinations to Europe, Asia and North America

As the share of fully vaccinated people continues to increase and societies are opening, travel is picking up in several markets. Finnair is meeting the increased travel demand by adding frequencies and destinations in its network to Europe, Asia and North America for the upcoming winter season. Finnair continues to serve its key Asian destinations, flying daily to Tokyo, Seoul and Bangkok, and offers multiple weekly frequencies to Singapore and Hong Kong. Finnair’s Osaka service resumes in October, expanding Finnair’s presence back into the Japanese market, with Nagoya joining this

Waystream continues to build in German fiber networks

Waystream has received another order in Germany and will in 2022 deliver switches for the build-out of a fiber network. The order has been placed by one of the leading suppliers of fiber-based broadband in Northern Europe, with special emphasis on Scandinavia and Germany.The agreement includes delivery of 4,800 customer connections. Waystream has won a deal in Germany, Europe's largest market, worth just over SEK 3 million in 2022. “It is a proof that our products meet the needs of the German market. As the requirements for availability and speed of Internet services increase, the

BioStock: Gabather poised to complete phase I with GT-002

As described in their Q2 report, despite the pandemic, Swedish biotech Gabather have taken key steps in the clinical development of its lead candidate GT-002 this year. Since the reporting period, the company has announced submitting an application for initiating a target engagement study with GT-002 in Portugal. If approved, this study will be a gateway to phase II and beyond. BioStock takes a look back at Gabather’s advancements so far this year and discusses the importance of this target engagement study with CEO Michael-Robin Witt.Read the full interview with Michael-Robin Witt at

The exercise price for the warrants of series TO1 in Cereno Scientific AB (publ) has been determined to SEK 2.85 per share

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Cereno Scientific AB (publ) (“Cereno” or the “Company”) issued warrants of series TO1 during the fourth quarter of 2020. Each warrant entitles the holder to subscribe for one (1)

Volvo Capital Market Day re-scheduled to spring 2022

The previously announced Volvo Group Capital Market Day set to take place on November 11, 2021 will be re-scheduled to spring 2022.The new date of the Capital Market Day will be announced well in advance along with information regarding whether attendance at the event will be virtual or in-person. Registration for the event on Volvo Group’s website will open closer to the date.September 14, 2021For further information, please contact:Johan Bartler, Volvo Group Investor Relations, +4673 902 2193, orClaes Eliasson, Volvo Group Media Relations, +46 76 553 72 29For more information,

Enersense International Plc: Flagging notification under chapter 9, section 10 of the Securities Markets Act

Enersense International PlcStock Exchange Release 14 September 2021 at 9.30 amEnersense International Plc has received a notification under chapter 9, section 5 of the Securities Markets Act from MBÅ Invest Oy. According to the notification, the shareholding of MBÅ Invest Oy in Enersense International Plc has fallen to 16.82% of all shares in Enersense International Plc on 13 September 2021. According to the notification, the company holds a total of 2 253 072 shares in Enersense International Plc, which corresponds to 16.82% of all shares and voting rights in Enersense International Plc.

Northmill expands to Norway

- Reduce aims to help Norwegians lower their interest ratesStockholm, September 14, 2021: The neobank Northmill , which has the vision of improving people's financial life, is entering the Norwegian market. The first step is an entry into the refinancing market with Reduce, which has already helped thousands of Swedes lower their interest rates on existing loans, installments and private loans. The refinancing market in Norway is estimated to be worth NOK 153 billion. With a tailor-made and proven service, the neobank aims to compete with the

Speqta and Rahalaitos recruits Ilari Heldan as Head of Digital marketing & Sales at Rahalaitos

Speqta (”SPEQT”) has recruited Ilari Heldan as Head of Digital Marketing and Sales for the Finnish loan broker Rahalaitos. Ilari has an extensive background from companies like Bonnier, Aller and Lendomatic. One of Finland’s most known brands in loan brokerage Rahalaitos is now adding competence within digital marketing. Ilari Heldan has background from multiple companies within traffic acquisition, media, and finance. At Lendomatic he was the country manager and during his career he has been working on a wide scale with lead generation. Ilari will assume the position on October

Large quantities of rare-earth minerals found in certain geothermal waters

In addition to producing zero-carbon heat and power, large quantities of rare-earth minerals may add additional cashflow from certain geothermal waters, pending local geology.Geothermal’s unique position in the future energy mix Large-scale renewable generation also requires large-scale power storage if energy is to be supplied steadily. Lithium-ion batteries are used to power electronic devices and store energy generated from wind and solar power, among their many other uses. Five times more lithium than is mined currently is going to be necessary to meet global climate targets by 2050,

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 13th September 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 25,562,916 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

The US based Pancreatic Cancer Action Network informs their members about Immunovia’s blood test IMMray™ PanCan-d

LUND, SWEDEN –Immunovia AB (publ) (“Immunovia”), a diagnostic company that develops and sells highly accurate blood tests for the early detection of cancer, today announced that the largest patient organization for pancreatic cancer in the US – Pancreatic Cancer Action Network (PanCAN) – informed their constituents about Immunovia, Inc.’s blood test IMMray™ PanCan-d on its website, in social media and through direct email contact. PanCAN underlines  that IMMray™ PanCan-d is the first-ever blood test specific for

FluoGuide proceeds to seventh dose level (36 mg) with FG001 in the ongoing clinical phase I/II trial following continued improvement of tumor illumination with increasing doses

Copenhagen, Denmark, 14 September 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that FG001 was well tolerated, and light was detected in all patients in the sixth cohort (24 mg), administered in the morning before surgery. The data from the sixth dose (24 mg) showed a continued improvement and clear illumination of the tumors in all three patients. The dose escalation committee has therefore recommended to initiate the seventh dose level (36 mg) in the ongoing clinical phase I/II trial.FluoGuide is conducting a clinical phase I/II trial evaluating safety and

Beactica Therapeutics appoints Head of Chemistry and two new members to its Board of Directors to strengthen its strategic focus on cancer

Beactica Therapeutics AB, the Swedish drug discovery & development company, today announced the appointment of a Head of Chemistry and two new members of the Board. The appointments are made to strengthen the organisation as the company further sharpens its strategic focus on developing novel cancer therapeutics.Dr Peter Brandt is appointed Head of Chemistry and brings with him more than 20 years of industrial experience in drug discovery & development. Before joining Beactica, Peter has held leading positions at AstraZeneca, the Department of Medicinal Chemistry at Uppsala University, KDev

Abacus Diagnostica, Kaivogen and Labrox joining forces to form a global diagnostics pioneer – Enabling the right diagnosis and care at the patient’s first appointment

Three Finnish biotech companies – Abacus Diagnostica, Kaivogen and Labrox – are joining forces to form an international frontrunner in in vitro diagnostics. The new company will provide the global market with a unique total solution for point-of-care testing, including diagnostics for infectious diseases and cancers.  The next-generation solution will enable testing anywhere and at any time, thereby speeding up the the correct diagnosis and care. Instead of sending samples to external laboratories, samples are taken and analysed near the patient. The launch of the new solution for point-of-

Metso Outotec to supply copper solvent extraction and electrowinning technology to US

Metso Outotec Corporation press release, September 14, 2021 at 9:00 am EESTMetso Outotec has signed an agreement with Florence Copper Inc., a subsidiary of Taseko Mines Limited, to supply copper solvent extraction and electrowinning technology for a plant to be built in Arizona. The order exceeding EUR 20 million has been booked in the Metals’ segment Q3/2021 orders received. The Metso Outotec delivery includes the modular VSF®X solvent extraction plant and the main process equipment for the electrowinning plant. “We are very excited to have purchased the key SX/EW process equipment

Peab builds apartments in Vantaa

Peab has been commissioned to build apartments in Vantaa. The customer is Sato-Rakennuttajat Oy and the contract is worth EUR 15 million.The project entails building two high-rises with a total of 159 apartments in Vantaa Keimolanmäki. “Our latest project together has just been completed and is ready to be turned over to our customer. This new project will be a great continuation of our successful collaboration with Sato. We are proud to be able to contribute to augmenting residential options for people in Vantaa,” says Marko Rinkinen, Region Manager Peab. The project is a turnkey

Heimstaden Bostad Sets New Targets to Limit Global Warming to 1.5°C

Heimstaden Bostad has set new sustainability targets and will invest SEK 5 billion to reduce the company’s greenhouse gas emissions by at least 46% by 2030, in line with the Paris Agreement ambition to limit global warming to 1.5°C.In January 2021, Heimstaden Bostad was one of the first pan-European residential real estate companies to commit to the Science Based Targets initiative (SBTi) and, after a thorough internal process and review of the operational and economic ramifications of raising its ambitions, the company is pleased to announce new climate targets: · Reduce greenhouse

Heimstaden Bostad Sets New Targets to Limit Global Warming to 1.5°C

Heimstaden AB's subsidiary, Heimstaden Bostad has set new sustainability targets and will invest SEK 5 billion to reduce the company’s greenhouse gas emissions by at least 46% by 2030, in line with the Paris Agreement ambition to limit global warming to 1.5°C.In January 2021, Heimstaden Bostad was one of the first pan-European residential real estate companies to commit to the Science Based Targets initiative (SBTi) and, after a thorough internal process and review of the operational and economic ramifications of raising its ambitions, the company is pleased to announce new climate targets:

First day of trading in CS MEDICA’s shares and warrants at Spotlight Stock Market

Today is the first day of trading in CS MEDICA A/S’s (”CS MEDICA” or the ”Company”)  shares and warrants. CS MEDICA’s shares are traded under the ticker “CSMED” with ISIN DK0061668225 and the Company’s warrants are traded under the ticker “CSMED TO 1” with ISIN DK0061668308.Prior to listing at Spotlight Stock Market, CS MEDICA conducted a successful IPO which was subscribed to a total of approx. 158 percent. The capitalization provided the Company with initially approx. DKK 22.3 million (before issue costs, offset of bridge loan financing and compensation). The number of shares in the

Instalco collaborates with Wayout on water purification in vulnerable areas

Instalco and Wayout International will begin collaborating on a project to increase access to clean water in vulnerable areas of the world.  Swedish Wayout is developing microfactories for local water purification that can then be used as drinking water.For many people around the world, clean drinking water is a scarce resource. Wayout offers turnkey micro-purification factories for local production and distribution of clean drinking water. They are distributed to vulnerable areas around the world. “Clean drinking water should be a basic human right. But unfortunately, it is a scarce

Abacus Diagnostica, Kaivogen and Labrox joining forces to form a global diagnostics pioneer – Enabling the right diagnosis and care at the patient’s first appointment

Three Finnish biotech companies – Abacus Diagnostica, Kaivogen and Labrox – are joining forces to form an international frontrunner in in vitro diagnostics. The new company will provide the global market with a unique total solution for point-of-care testing, including diagnostics for infectious diseases and cancers.  The next-generation solution will enable testing anywhere and at any time, thereby speeding up the the correct diagnosis and care. Instead of sending samples to external laboratories, samples are taken and analysed near the patient. The launch of the new solution for point-of-

Abacus Diagnostica, Kaivogen and Labrox joining forces to form a global diagnostics pioneer – Enabling the right diagnosis and care at the patient’s first appointment

Three Finnish biotech companies – Abacus Diagnostica, Kaivogen and Labrox – are joining forces to form an international frontrunner in in vitro diagnostics. The new company will provide the global market with a unique total solution for point-of-care testing, including diagnostics for infectious diseases and cancers.  The next-generation solution will enable testing anywhere and at any time, thereby speeding up the the correct diagnosis and care. Instead of sending samples to external laboratories, samples are taken and analysed near the patient. The launch of the new solution for point-of-

There are no items matching the current filter
There are no more items matching the current filter
Back to top